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Abstract
Introduction: Quantitative imaging biomarkers are becoming usual in oncology
for assessing therapy response. The harmonization of image quantitation
reporting has become of utmost importance due to the multi-center trials
increase. The NEMA image quality test is often considered for the evaluation of
quantitation and is more accurate with a radioactive solid phantom that reduces
variability. The goal of this project is to determine the level of variability among
imaging centers if acquisition and imaging protocol parameters are left to the
center’s preference while all other parameters are fixed including the scanner
type.
Methods: A NEMA-IQ phantom filled with radioactive 68Ge solid resin was
imaged in five clinical sites throughout Europe. Sites reconstructed data with
OSEM and BSREM algorithms applying the sites’ clinical parameters. Images were
analyzed according with the NEMA-NU2-2012 standard using the manufacturer-
provided NEMA tools to calculate contrast recovery (CR) and background
variability (BV) for each sphere and the lung error (LE) estimation. In addition, a
18F-filled NEMA-IQ phantom was also evaluated to obtain a gauge for variability
among centers when the sites were provided with identical specific instructions
for acquisition and reconstruction protocol (the aggregate of data from 12
additional sites is presented).
Results: The data using the 68Ge solid phantom showed no statistical
differences among different sites, proving a very good reproducibility among the
PET center models even if dispersion of data is higher with OSEM compared to
BSREM. Furthermore, BSREM shows better CR and comparable BV, while LE is
slightly reduced. Two centers exhibit significant differences in CR and BV values
for the 18F NEMA NU2-2012 experiments; these outlier results are explained.
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© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit
line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
EJNMMI PhysicsVallot et al. EJNMMI Physics            (2020) 7:30 
https://doi.org/10.1186/s40658-020-00294-y
(Continued from previous page)
Conclusion: The same PET system type from the various sites produced similar
quantitative results, despite allowing each site to choose their clinical protocols
with no restriction on data acquisition and reconstruction parameters. BSREM
leads to lower dispersion of quantitative data among different sites. A solid
radioactive phantom may be recommended to qualify the sites to perform
quantitative imaging.
Keywords: PET/CT, Multi-center harmonization, quantitation, 18F-FDG NEMA body
phantom, 68Ge solid phantom
Introduction
The current clinical trend is to use PET/CT as a quantitative biomarker in oncology
for assessing the reliable evaluation of lesion’s uptake changes over time. The standard-
ized uptake value (SUV) is still the standard quantitative index in positron emission
tomography (PET), but new surrogates are now reported as references like response
criteria in solid tumors (PERCIST) [1], metabolic active tumor volumes (MATV), or
total lesion glycolysis (TLG) [2].
For all these new quantitative indexes, long-term accuracy and reproducibility
are mandatory [3, 4]. Nevertheless, these parameters are known to be strongly in-
fluenced by various factors such as injected activity, uptake and acquisition time,
reconstruction parameters, and lesion’s dimension and localization [5, 6]. The
technological advances and design improvements in PET systems lead to higher
sensitivities and are now associated with advanced reconstruction algorithms in-
cluding accurate corrections applied during the iterative process (e.g., point
spread function (PSF), time of flight (TOF), block sequential regularized expect-
ation maximization (BSREM) for noise regularization). As a result, this large
number of parameters lead to variations observed in quantitative measurements
[7]. The need for harmonization in quantitative reporting has become of the ut-
most importance due to the increasing number of multi-center clinical trials. Sev-
eral protocols are available to limit the differences among the scans outcome, from
the patient preparation to the final report: for instance, the Uniform Protocols for
Imaging in Clinical Trials (UPICT), the ResEARrch 4 Life (EARL) accreditation
protocol, or the EANM FDG guidelines [7–9]. These protocols are expected to in-
crease SUV’s absolute evaluation, but not all the sites in Europe are currently
accredited by EANM.
Chauvie et al. [10] clearly demonstrated that the use of a radioactive phantom
filled with long-lived decaying isotopes could reduce sources of error such as
dose calibrator variability and site-specific physicist hands-on training and
experiences.
Encouraged by the above evidence, we aimed in this research to evaluate the
relevance of mixing quantitative results coming from multisite PET exams among
European facilities involved in a multi-center clinical trial. The QUICK project
(Quantitation Unified Intercomparison Control Kit) was launched with the pur-
pose of evaluating the impact of clinical protocol differences over scanner intro-
duced variability. We realize the variability introduced with different scanner
Vallot et al. EJNMMI Physics            (2020) 7:30 Page 2 of 13
types is the ultimate goal for such a comparison, but we focus on protocol vari-
ability impact first as the initial step to understand the larger picture.
With the purpose of understanding the impact of different scanner operators, the
same acquisitions and reconstructions were done on each site using the QUICK phan-
tom. This step was followed with a series of acquisitions and reconstructions using
local setup preferences as well as the site’s recommendations for clinical
reconstruction.
The final statistical analysis of all data provided by the sites was expected to
point out the impact of sites’ clinical practice on absolute quantitation in terms of
contrast recovery, background variability, and lung error.
Results obtained using optimized protocols should be compared within the different
participating sites to evaluate the global achievable accuracy of the multi-center clinical
trials.
In summary, the aim of this study was to estimate the global statistical multi-center
quantitation accuracy taking into account the discrepancies between participating PET
facilities, using a solid phantom with fixed and accurately known activities and
volumes.
The auxiliary aim of this collaborative work was to evaluate the impact of
BSREM reconstruction on quantitation reliability, which is a unique feature of GE’s
D-IQ PET-CT scanner selected for this multi-center study.
Materials and methods
All the participating sites were equipped with a GE Discovery IQ PET/CT sys-
tem, which is a state-of-the-art bismuth germanate (BGO) PET. It offers very
high sensitivity and, associated with a new regularization algorithm (BSREM)
named Q.Clear [11], raises an opportunity to get more accurate quantitation.
Moreover, its high sensitivity allows to redefine dose prescription and exam
durations.
The acquisitions were performed by medical physicists on fully calibrated PET/CT
scanners.
In order to evaluate quantitation performance, the NEMA-defined parameters
contrast recovery (CR) and background variability (BV) were collected and analyzed
[12–15].
In the BSREM reconstruction algorithm, the noise penalty function strength named
“Beta ” (β) is directly correlated with CR and BV. Consequently, it is relevant to this
study to keep track of the site’s preference in β value selection. This penalty term pro-
vides level of regularization based on the difference between neighboring voxels as well
as their sum.
A solid 68Ge phantom (QUICK phantom) based on IEC61675/NEMA Body IQ phan-
tom geometry and activity concentrations was manufactured for this study allowing a
better identification of the eventual causes of quantitative discrepancies among the par-
ticipating sites.
In order to avoid discrepancies related to data analysis in each participating site, it
was decided to use the built-in software provided by GE Healthcare and available on
operating console to perform NEMA NU-2 2012 image quality test.
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18F-FDG phantom acquisition
In the first part of the study, data from standard NEMA image quality test
with an 18F-FDG phantom from seventeen different sites across Europe were
combined. Each of the participating sites followed the manufacturer-provided
protocol conducting three acquisitions with the IEC61675/NEMA NU2-2012
PET Image Quality Body Phantom. This phantom is a torso-like cavity contain-
ing 6 hollow spheres (internal diameters of 10, 13, 17, 22, 28, and 37 mm) sur-
rounding a lung insert. The phantom was filled on each site with an 18F-FDG
solution of approximately 53 MBq at the start of acquisition (Fig. 1a). The four
smallest spheres were filled keeping sphere (21.2 kBq/ml) to background (5.3
kBq/mL) ratio of 4:1, while the largest two spheres were filled with water. The
lung insert was filled with a non-radioactive mix of water and Styrofoam
beads.
According to the NEMA NU2-2012 image quality test, there was also out-of-field ac-
tivity (120MBq) in a line source in the scatter-fraction phantom.
The acquisition and reconstruction parameters for the NEMA procedure, followed
during the 18F-FDG phantom tests, are listed in Table 1.
QUICK phantom acquisition
Five1 out of the seventeen sites performed acquisitions with the QUICK solid
radioactive phantom (68Ge) (Fig. 1b) that was designed and manufactured by Eck-
ert & Ziegler2 to meet the IEC61675/NEMA NU2-2012 image quality body phan-
tom features (6 spheres and a lung insert). To meet the requirements of this
Fig. 1 a Scheme of the IEC61675/NEMA NU2-2012 Image Quality Body Phantom (in black the cold spheres
and in gray the hot spheres) and b a picture of the QUICK phantom
1Institut Universitaire du Cancer de Toulouse (France), ASST Monza (Italy), Affidea Wroclaw 3 (Poland),
Affidea Poznan 1 (Poland), and Hospital Universitari de Bellvitge—IDIBELL (Spain)
2Eckert & Ziegler Isotope Products, Inc., 24937 Avenue Tibbitts, Valencia, CA 91355
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standard procedure, the total 68Ge activity in the phantom was 63.94 MBq at cali-
bration, allowing a relatively easy shipment from one site to another. The two
biggest spheres (28 and 37 mm in diameter) were made of cold resin (non-radio-
active) and the four smallest ones with 68Ge resin at a concentration of 25.2 kBq/
mL. The background activity concentration was at 6.36 kBq/mL so that the ratio
of spheres to background was 3.96:1. Contrary to the NEMA NU2-2012 image
quality test, there was no out-of-field activity during the acquisitions to avoid any
unexpected effect of external source positioning.
The five centers involved in the QUICK phantom acquisition are identified in this
paper as QUICK sites 1–5.
The data acquisition involved 5 measurements per day for a span of 5 days to ac-
count for the effect of the Poisson statistics and variability in phantom positioning,
respectively. Thus, a dataset of 25 images have been used for this analysis for each
site. Table 2 summarizes the acquisition and reconstruction parameters for the dif-
ferent tests.
In test 1, the QUICK phantom was scanned with the acquisition and reconstruc-
tion parameters recommended by the manufacturer for the standard NEMA NU2-
2012 procedure (same as in Table 1 for the 18F-FDG phantom). The NEMA-IQ
protocol recommended by the manufacturer does not include PSF because not all
Table 1 Acquisition and reconstruction parameters for the standard NEMA test with 18F-FDG
phantom
CT parameters PET parameters
Scan type: helical, full Scan time: 5 min 52 s, 6 min 06 s, 6 min 21 s
Tube voltage: 120 kV Matrix size: 256 × 256
Tube rotation: 0.5 s DFOV: 40 cm
Auto mA modulation Attenuation correction type: CT
Slice thickness: 3.75 mm Recon type: VPHD
DFOV: 70 cm Iterations: 8
Subsets:12
Post-filter cutoff: 2 mm
Z-axis filter: none
Table 2 Summary of the test format (overview) realized with the QUICK phantom in each QUICK
site. The rows denote the acquisition parameters (NEMA protocol/clinical protocol for the particular
site), and the columns represent the reconstruction parameters (NEMA protocol/clinical protocol
for the particular site) used in the test
Reconstruction parameters
NEMA Clinical
OSEM BSREM (β = 25) OSEM BSREM
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users have access to PSF, whereas a user with access to BSREM automatically in-
cludes access to PSF.
In test 2, the RAW data was re-processed using the BSREM algorithm and a β
value of 25 optimized to match the background noise level (BV) observed in the
corresponding OSEM reconstruction (test 1). Increasing beta value results in
smoother background (preferred by physicians) at the expense of reduced contrast
recovery [16]. This avenue was not explored as the intent of the paper is to com-
pare site to site variations, not the impact of different beta values in clinical
images.
In test 3 and test 4, each QUICK site re-processed the same RAW data using
their own clinical reconstruction parameters optimized for OSEM and BSREM al-
gorithms, respectively. For OSEM, the number of iterations for clinical recon-
struction was the site’s choice as preferred by the site’s reading physicians and is
a compromise between signal recovery and background noise level. The number
of iterations for BSREM (25 iterations) is selected by the manufacturer until
convergence is reached as intrinsically established by the BSREM algorithm
(Table 2).
In test 5 and test 6, the QUICK phantom was re-scanned in each site with its
own clinical acquisition protocol (in terms of FOV (field of view), scan time, and
acquisition matrix) and re-processed with clinically optimized OSEM and BSREM
algorithms already used in test 3 and test 4, respectively.
Detailed acquisition and reconstruction parameters for each test are shown in
Table 3.
In each site, the acquisition time for the QUICK phantom was adjusted to com-
pensate for the decay of 68Ge activity over time to meet the NEMA NU2-2012
Table 3 Acquisition and reconstruction parameters for each test
Test 1 Test 3 Test 5
Matrix size 256 256 256
FOV (cm) 40 40–70 40–70
Reconstruction algorithm OSEM OSEM OSEM
Iterations 8 4–6 4–6
Subsets 12 12 12
Filter (FWHM) 2 4.8–6.4 4.8–6.4
Z-filter None Standard (weight 1 4 1) Standard (weight 1 4 1)
Corrections CTAC, scatter, randoms CTAC, scatter, randoms CTAC, scatter, randoms
PSF correction No Yes/no Yes/no
Test 2 Test 4 Test 6
Matrix size 256 256 256
FOV (cm) 40 40–70 40–70
Reconstruction algorithm BSREM BSREM BSREM
Iterations 25 25 25
β 25 350 350
Corrections CTAC, scatter, randoms CTAC, scatter, randoms CTAC, scatter, randoms
PSF correction Yes Yes Yes
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(test 1 to test 4) or to meet the clinical protocol (test 5 and test 6) count
requirements.
Data analysis
For a consistent analysis, all the datasets were analyzed by each site using the au-
tomated GE NEMA image quality analysis software available on the operating
console: CR and BV for each sphere in the phantom were calculated using each
reconstruction method. Similarly, the LE was also determined using each recon-
structed method. These variables are defined in the NEMA standards publication
NU2-2012 image quality test [17].
Results
18F-FDG phantom acquisition
The results of the NEMA NU2-2012 image quality test, in terms of CR, BV, and LE,
are presented in Fig. 2, Fig. 3, and Fig. 4, respectively.
As expected, the majority of participating centers obtained similar results, and only
two centers (QUICK Site 4 and QUICK site 5) showed unexpected data.
Excluding these 2 centers, the CR values range from 30.8–43.6 to 63.7–77.2 from the
smallest to the largest of the hot spheres, respectively. For the cold spheres (28 mm and
37mm), the same parameter ranges from 65.7–75.4 to 73–79.1.
QUICK phantom acquisition
The results of the six QUICK phantom tests, as average and standard deviation of
acquisitions among all QUICK sites, are shown in Table 4 (Figure 5 for graphic
plot) and Fig. 6 and Fig. 7.
Fig. 2 CR (%) values for the standard NEMA test performed with 18F-FDG phantom
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Discussion
The most often recommended procedure to evaluate the quantitation variability
among PET facilities is to perform acquisitions and reconstruction of a fillable
image quality phantom using the local setting of parameters and to extract
quantitative data from resulting images. Following suit, the first part of this
project showed that the variability introduced in the filling of the 18F-filled
NEMA-IQ phantoms, scanned and imaged following same protocols across sites,
is larger than the one from a 68Ge filled phantom where each site was allowed
Fig. 4 Lung error (LE in %) values for the standard NEMA test performed with
18F-FDG phantom
Fig. 3 BV (%) values for the standard NEMA test performed with an 18F-FDG phantom
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to select the acquisition and reconstruction protocols. The main goal of limiting
to a single scanner type (D-IQ from GE) was to control all other parameters in
this comparison except for the imaging protocol selection between sites. This
conclusion is further supported by the small variability observed when same im-
aging protocol is used with the QUICK phantom.
In this study, we have tried to assess and demonstrate the possibility of performing
quantitative multisite clinical trials in PET using QUICK phantom. In addition, we also
made an effort to understand the impact and potential causes of discrepancies among
different sites if any.
Table 4 CR, BV, and LE for the six tests performed with QUICK phantom as average ± standard



















Sphere Contrast recovery (%): average ± SD
10 mm 29.4 ± 2.0 39.9 ± 2.5 17.9 ± 1.6 17.6 ± 2.4 18.0 ± 2.1 18.8 ± 1.1
13 mm 42.9 ± 1.6 53.5 ± 1.1 30.8 ± 3.0 34.1 ± 3.4 30.7 ± 3.0 36.1 ± 2.2
17 mm 52.9 ± 1.6 61.4 ± 1.5 45.0 ± 4.3 49.5 ± 3.1 43.8 ± 4.4 50.2 ± 1.6
22 mm 60.5 ± 1.2 67.5 ± 1.4 54.8 ± 4.5 60.7 ± 2.6 54.9 ± 4.3 61.6 ± 0.5
28 mm 67.9 ± 0.7 77.7 ± 1.0 59.3 ± 1.6 66.8 ± 2.4 59.3 ± 1.7 67.5 ± 1.5
37 mm 74.6 ± 0.4 83.1 ± 0.6 66.6 ± 2.3 75.9 ± 1.8 66.9 ± 1.7 76.9 ± 1.1
Sphere Background variability (%): average ± SD
10 mm 7.4 ± 2.1 8.9 ± 0.6 4.3 ± 1.8 4.0 ± 1.2 4.7 ± 1.8 4.8 ± 1.6
13 mm 5.9 ± 1.6 7.1 ± 0.5 3.8 ± 1.6 3.5 ± 1.1 4.2 ± 1.6 4.2 ± 1.4
17 mm 4.6 ± 1.2 5.4 ± 0.4 3.2 ± 1.3 3.0 ± 0.8 3.6 ± 1.4 3.5 ± 1.2
22 mm 3.6 ± 0.9 4.1 ± 0.3 2.8 ± 1.1 2.4 ± 0.6 3.1 ± 1.2 2.9 ± 0.9
28 mm 2.8 ± 0.7 3.1 ± 0.3 2.3 ± 0.9 2.0 ± 0.4 2.6 ± 0.9 2.3 ± 0.7
37 mm 2.2 ± 0.5 2.4 ± 0.2 2.0 ± 0.7 1.7 ± 0.4 2.3 ± 0.8 1.9 ± 0.5
Lung error (%): average ± SD
16.4 ± 0.5 12.2 ± 0.6 23.1 ± 1.4 14.3 ± 1.1 22.6 ± 2.5 13.1 ± 1.3
Fig. 5 Contrast recovery and background variability for test 1 for the QUICK sites
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In order to avoid additional possible causes of discrepancies, we decided to ex-
tract quantitative data using the automatic processing available on the scanner’s
console.
As mentioned above, two centers of the 17 sites (QUICK site 4 and QUICK site
5) showed unexpected data from the 18FDG phantom, despite having detailed di-
rections for filling and imaging of the phantom. Their results can be explained
by placing a larger than prescribed ratio of activity concentration between
spheres and background (QUICK site 5) and too high activity in the background
above the NEMA prescribed value (QUICK site 4).
These results clearly demonstrate the possible issues when trying to compare sys-
tems using 18F-FDG fillable phantom due to a different level of experience of the
operators (e.g., handling of FDG, accurate filling of the spheres, careful alignment
of the phantom). A solid radioactive phantom filled with 68Ge can be used to avoid
such errors [10], and the reproducibility of the measurements can thus be
enhanced.
Results of the standard NEMA test using the QUICK phantom support this assess-
ment by showing more consistent results.
Fig. 6 CR (left column) and BV (right column). Top row, tests 1 and 2. Middle row, tests 3 and 4. Bottom
row, tests 5 and 6. All tests were performed with the QUICK phantom
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With equal acquisition conditions among sites, the BSREM algorithm gives bet-
ter or similar results than the OSEM algorithm, i.e., higher CR, lower or similar
BV, and a lower LE. The exceptions are due to the specific selection of β value
(25) was intended to produce comparable background variability in the BSREM
images with respect to OSEM images. This selection was not optimal, particularly
for smaller ROIs (Fig. 5 top right), highlighting the trade between beta selection
and CR. Larger clinical beta values (e.g., 350) produce smoother images at the ex-
pense of CR.
In general, all the tests performed using the 68-Ge QUICK phantom led to
small variability of the CR which is the most relevant parameter in the perspec-
tive of quantitative PET studies. One aspect of the results presented here, that is
“the 68Ge NEMA-IQ standard NEMA-2012 test”, provides a unique opportunity
to observe the variability introduced from scanner to scanner when most other
variables are confined to a very small change of their own.
Focusing on test 6 (the site’s clinical acquisition and reconstruction parame-
ters), BSREM algorithm reduces the CR variability among sites when compared
with the OSEM algorithm. This result supports the use of BSREM as the pre-
ferred protocol in a multi-center clinical trial regardless of the site-specific beta
value. This may reduce the variability introduced by patient size and body habitus
[18].
Logistical challenges in transporting the QUICK phantom from site to site (e.g.,
custom approvals, local regulations with respect to transport and handling of
radioactive material), resulted in delays of sites performing the measurements.
Hence, each site performed the measurements with different total activity of the
phantom. We compensated the decaying activity through longer acquisition times.
However, it should be noticed that the acquisition conditions are not fully
equivalent as the ratio of true events to random events does not remain constant
with changing activity.
Fig. 7 LE values for the six tests performed with the QUICK phantom
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The QUICK project was designed as a phantom study for comparing recon-
struction protocols and selection of parameters. Hence, it does not take into ac-
count other parameters like dose calibrator, injected activity, serum glucose
level, and post-injection time. To minimize variability of these parameters,
multi-center participants must meet accreditation requirements that should in-
clude, for instance, the use of traceable sources for calibration of their dose cali-
brator, and similar patient preparation [7, 19].
Conclusion
This study demonstrates the variability introduced by using different imaging pro-
tocols is smaller than the variability introduced by the operator when a NEMA-IQ
phantom is handled and imaged by different sites following identical protocols. In
turn, this demonstrates that the use of phantoms like the NEMA-IQ phantom for
multi-center evolution of protocols is unreliable.
BSREM algorithm reduces the variability of contrast recovery in PET images
compared to the OSEM algorithm in different clinical acquisition conditions and
reconstruction parameters across multiple centers. In the future, we plan to study
the impact of the patient’s preparation on the variability of these measurements
and to evaluate if harmonization of the injected dose is a necessary requirement
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